Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Abstract 3020: The tumor suppressive role of methylthioadenosine phosphorylase in melanoma

Jennifer J. Hsiao, Pedro Andreu-Perez, Lajos V. Kemény, Miroslav Hejna, Jérémie Nsengimana, Jennifer Allouche, Abdullah Al Emran, D. Timothy Bishop, Göran B. Jönsson, Julia Newton-Bishop, Jun Song, David E. Fisher

Cancer Res (2024) 84 (6_Supplement): 3020.

https://doi.org/10.1158/1538-7445.AM2024-3020

Published: 22 March 2024

View article titled, Abstract 3020: The tumor suppressive role of methylthioadenosine phosphorylase in melanoma

Journal Articles

Abstract 1706: A non-canonical MiT/TFE-dependent NRF2 program is a druggable vulnerability in multiple cancer types

Cancer Res (2023) 83 (7_Supplement): 1706.

https://doi.org/10.1158/1538-7445.AM2023-1706

Published: 04 April 2023

View article titled, Abstract 1706: A non-canonical MiT/TFE-dependent NRF2 program is a druggable vulnerability in multiple cancer types

Journal Articles

SOX10 Regulates Melanoma Immunogenicity through an IRF4–IRF1 Axis

Satoru Yokoyama, Atsushi Takahashi, Ryota Kikuchi, Soshi Nishibu, Jennifer A. Lo, Miroslav Hejna, Wooyoung M. Moon, Shinichiro Kato, Yue Zhou, F. Stephen Hodi, Jun S. Song, Hiroaki Sakurai, David E. Fisher, Yoshihiro Hayakawa

Cancer Res (2021) 81 (24): 6131–6141.

https://doi.org/10.1158/0008-5472.CAN-21-2078

Published: 15 December 2021

View article titled, SOX10 Regulates Melanoma Immunogenicity through an IRF4–IRF1 Axis

Includes: Supplementary data

Journal Articles

Abstract 3428: The role of methylthioadenosine phosphorylase in melanoma

Jennifer Jia-An Hsiao, Pedro Andreu-Perez, Miroslav Hejna, Lajos V. Kemény, Jun Song, David E. Fisher

Cancer Res (2020) 80 (16_Supplement): 3428.

https://doi.org/10.1158/1538-7445.AM2020-3428

Published: 15 August 2020

View article titled, Abstract 3428: The role of methylthioadenosine phosphorylase in melanoma

Journal Articles

Abstract 62: Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies

Joan Montero, Cecile Gstalder, Daniel J. Kim, Dorota Sadowicz, Wayne Miles, Michael Manos, Justin R. Cidado, J. Paul Secrist, Adriana E. Tron, Keith Flaherty, F. Stephen Hodi, Charles H. Yoon, Anthony Letai, David E. Fisher, Rizwan Haq

Cancer Res (2020) 80 (16_Supplement): 62.

https://doi.org/10.1158/1538-7445.AM2020-62

Published: 15 August 2020

View article titled, Abstract 62: Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies

Journal Articles

The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD⁺ Depletion–Mediated Cytotoxicity

Kensuke Tateishi, Fumi Higuchi, Julie J. Miller, Mara V.A. Koerner, Nina Lelic, Ganesh M. Shankar, Shota Tanaka, David E. Fisher, Tracy T. Batchelor, A. John Iafrate, Hiroaki Wakimoto, Andrew S. Chi, Daniel P. Cahill

Cancer Res (2017) 77 (15): 4102–4115.

https://doi.org/10.1158/0008-5472.CAN-16-2263

Published: 01 August 2017

View article titled, The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity

Includes: Supplementary data

Journal Articles

Abstract 1019: In vivo CRISPR screening identifies Ptpn2 as a target for cancer immunotherapy

Robert T. Manguso, Hans W. Pope, Margaret D. Zimmer, Flavian D. Brown, Kathleen B. Yates, Brian C. Miller, Natalie B. Collins, Kevin Bi, Martin W. Lafleur, Vikram R. Juneja, Sarah A. Weiss, David E. Fisher, David E. Root, Arlene H. Sharpe, John G. Doench, W Nicholas Haining

Cancer Res (2017) 77 (13_Supplement): 1019.

https://doi.org/10.1158/1538-7445.AM2017-1019

Published: 01 July 2017

View article titled, Abstract 1019: In vivo CRISPR screening identifies Ptpn2 as a target for cancer immunotherapy

Journal Articles

Abstract A13: MSX1-induced neural crest-like reprograming promotes melanoma progression

Markus V. Heppt, Wang X. Joshua, Denitsa M. Hristova, Zhi Wei, Martin Irmler, Carola Berking, Robert Besch, Johannes Beckers, Frank J. Rauscher, III, David E. Fisher, Meenhard Herlyn, Mizuho Fukunaga-Kalabis

Cancer Res (2015) 75 (14_Supplement): A13.

https://doi.org/10.1158/1538-7445.MEL2014-A13

Published: 16 July 2015

View article titled, Abstract A13: MSX1-induced neural crest-like reprograming promotes melanoma progression

Journal Articles

Abstract IA21: Skin pigmentation pathways and melanoma risk

David E. Fisher

Cancer Res (2015) 75 (14_Supplement): IA21.

https://doi.org/10.1158/1538-7445.MEL2014-IA21

Published: 16 July 2015

View article titled, Abstract IA21: Skin pigmentation pathways and melanoma risk

Journal Articles

Abstract PR6: Why redheads are at increased risk of melanoma: A novel BRAF mutant mouse model

Devarati Mitra, Xi Luo, Daniel A. Haber, David E. Fisher

Cancer Res (2011) 71 (18_Supplement): PR6.

https://doi.org/10.1158/1538-7445.FBCR11-PR6

Published: 28 October 2014

View article titled, Abstract PR6: Why redheads are at increased risk of melanoma: A novel BRAF mutant mouse model

Journal Articles

Abstract 2950: Regulation of the functional interface between nucleotide excision repair and transcription by MITF modulates melanoma growth

Marcos Seoane, Laia Pagerols Raluy, Karoline Kaufmann, Julia Strauss, Kevin Dierck, Jüergen Thomale, Johanna M. Brandner, Udo Schumacher, Peter Nollau, Peter J. Wild, Martin Zimmermann, Jinyan Du, David E. Fisher, Martin A. Horstmann

Cancer Res (2014) 74 (19_Supplement): 2950.

https://doi.org/10.1158/1538-7445.AM2014-2950

Published: 01 October 2014

View article titled, Abstract 2950: Regulation of the functional interface between nucleotide excision repair and transcription by MITF modulates melanoma growth

Journal Articles

Abstract 4832: Isolation and molecular characterization of circulating melanoma cells

Xi Luo, Devarati Mitra, Ryan J. Sullivan, Ben S. Wittner, Anya M. Kimura, Shiwei Pan, Mai P. Hoang, Brian W. Brannigan, Donald P. Lawrence, Keith T. Flaherty, Lecia V. Sequist, Shannon L. Stott, David T. Ting, Sridhar Ramaswamy, Mehmet Toner, David E. Fisher, Shyamala Maheswaran, Daniel A. Haber

Cancer Res (2014) 74 (19_Supplement): 4832.

https://doi.org/10.1158/1538-7445.AM2014-4832

Published: 01 October 2014

View article titled, Abstract 4832: Isolation and molecular characterization of circulating melanoma cells

Journal Articles

Abstract LB-19: The Smac mimetic LBW242 induces apoptosis in melanoma in a TLR-3-dependent and TNFR-independent manner

Kevin T. McHenry, Elena Jacobson, Jerry Donovan, Kymberly Levine, Jingxin Zhang, David E. Fisher, Leigh Zawel, Dale Porter

Cancer Res (2011) 71 (8_Supplement): LB-19.

https://doi.org/10.1158/1538-7445.AM2011-LB-19

Published: 15 April 2011

View article titled, Abstract LB-19: The Smac mimetic LBW242 induces apoptosis in melanoma in a TLR-3-dependent and TNFR-independent manner

Journal Articles

Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Jennifer A. Wargo, Alex Cogdill, Ping Dang, Ridhi Gupta, Adriano Piris, Andrea Boni, Haven R. Garber, Harald Ott, Lindsay P. Newton, Keith T. Flaherty, Donald P. Lawrence, Hensin Tsao, David E. Fisher

Cancer Res (2011) 71 (8_Supplement): 958.

https://doi.org/10.1158/1538-7445.AM2011-958

Published: 15 April 2011

View article titled, Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Journal Articles

Selective BRAF^V600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function

Andrea Boni, Alexandria P. Cogdill, Ping Dang, Durga Udayakumar, Ching-Ni Jenny Njauw, Callum M. Sloss, Cristina R. Ferrone, Keith T. Flaherty, Donald P. Lawrence, David E. Fisher, Hensin Tsao, Jennifer A. Wargo

Cancer Res (2010) 70 (13): 5213–5219.

https://doi.org/10.1158/0008-5472.CAN-10-0118

Published: 30 June 2010

View article titled, Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function

Includes: Supplementary data

Journal Articles

Abstract 268: Regulation and function of ERBB3 signaling pathway in clear cell sarcoma

Yixiang Zhang, Ian J. Davis, Stephen P. Remillard, George D. Demetri, David E. Fisher, Andrew J. Wagner

Cancer Res (2010) 70 (8_Supplement): 268.

https://doi.org/10.1158/1538-7445.AM10-268

Published: 15 April 2010

View article titled, Abstract 268: Regulation and function of ERBB3 signaling pathway in clear cell sarcoma

Journal Articles

An Oncogenic Role for ETV1 in Melanoma

Judit Jané-Valbuena, Hans R. Widlund, Sven Perner, Laura A. Johnson, Aurora C. Dibner, William M. Lin, Alissa C. Baker, Rosalynn M. Nazarian, Krishna G. Vijayendran, William R. Sellers, William C. Hahn, Lyn M. Duncan, Mark A. Rubin, David E. Fisher, Levi A. Garraway

Cancer Res (2010) 70 (5): 2075–2084.

https://doi.org/10.1158/0008-5472.CAN-09-3092

Published: 28 February 2010

View article titled, An Oncogenic Role for ETV1 in Melanoma

Includes: Supplementary data

Journal Articles

Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma

Ian J. Davis, Andrew W. McFadden, Yixiang Zhang, Angela Coxon, Teresa L. Burgess, Andrew J. Wagner, David E. Fisher

Cancer Res (2010) 70 (2): 639–645.

https://doi.org/10.1158/0008-5472.CAN-09-1121

Published: 13 January 2010

View article titled, Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma

Includes: Supplementary data

Journal Articles

Mechanism of Regulation and Suppression of Melanoma Invasiveness by Novel Retinoic Acid Receptor-γ Target Gene Carbohydrate Sulfotransferase 10

Xiansi Zhao, Carole Graves, Sarah J. Ames, David E. Fisher, Remco A. Spanjaard

Cancer Res (2009) 69 (12): 5218–5225.

https://doi.org/10.1158/0008-5472.CAN-09-0705

Published: 15 June 2009

View article titled, Mechanism of Regulation and Suppression of Melanoma Invasiveness by Novel Retinoic Acid Receptor-γ Target Gene Carbohydrate Sulfotransferase 10

Includes: Supplementary data

Journal Articles

TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition

Masumi Tsuda, Ian J. Davis, Pedram Argani, Neerav Shukla, Gael G. McGill, Makoto Nagai, Tsuyoshi Saito, Marick Laé, David E. Fisher, Marc Ladanyi

Cancer Res (2007) 67 (3): 919–929.

https://doi.org/10.1158/0008-5472.CAN-06-2855

Published: 05 February 2007

View article titled, TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition

Includes: Supplementary data

NARROW

Abstract 3020: The tumor suppressive role of methylthioadenosine phosphorylase in melanoma

Abstract 1706: A non-canonical MiT/TFE-dependent NRF2 program is a druggable vulnerability in multiple cancer types

SOX10 Regulates Melanoma Immunogenicity through an IRF4–IRF1 Axis

Abstract 3428: The role of methylthioadenosine phosphorylase in melanoma

Abstract 62: Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies

The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1-Mutant Cancers and Potentiates NAD⁺ Depletion–Mediated Cytotoxicity

Abstract 1019: In vivo CRISPR screening identifies Ptpn2 as a target for cancer immunotherapy

Abstract A13: MSX1-induced neural crest-like reprograming promotes melanoma progression

Abstract IA21: Skin pigmentation pathways and melanoma risk

Abstract PR6: Why redheads are at increased risk of melanoma: A novel BRAF mutant mouse model

Abstract 2950: Regulation of the functional interface between nucleotide excision repair and transcription by MITF modulates melanoma growth

Abstract 4832: Isolation and molecular characterization of circulating melanoma cells

Abstract LB-19: The Smac mimetic LBW242 induces apoptosis in melanoma in a TLR-3-dependent and TNFR-independent manner

Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Selective BRAF^V600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function

Abstract 268: Regulation and function of ERBB3 signaling pathway in clear cell sarcoma

An Oncogenic Role for ETV1 in Melanoma

Identification of the Receptor Tyrosine Kinase c-Met and Its Ligand, Hepatocyte Growth Factor, as Therapeutic Targets in Clear Cell Sarcoma

Mechanism of Regulation and Suppression of Melanoma Invasiveness by Novel Retinoic Acid Receptor-γ Target Gene Carbohydrate Sulfotransferase 10

TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only